Sofosbuvir: Clinical Trials

2 trials of Sofosbuvir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Sofosbuvir: new trials by email Literature Review of Sofosbuvir trials Research Report on Sofosbuvir

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)
Sofosbuvir (SOF) and Ledipasvir (LDV) - Hepatitis C Viral Infection
Phase 3TerminatedUniversity Health Network, Toronto12015-06-012016-08-08
Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV) - Hepatitis C
Phase 3TerminatedUniversity of Colorado, Denver92015-05-012021-09-13

Conditions studied

Hepatitis C (1)

Sponsors

University Health Network, Toronto (1)  ·  University of Colorado, Denver (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Amanda Wieland, MD (1)  ·  Eberhard Renner, M.D. (1)

Results publications

PMID 17593061, PMID 17635375, PMID 17850410, PMID 18266997, PMID 19053983, PMID 8213790, PMID 9346731

NIH funding

UL1TR001082 (1)